MENU
+Compare
DNTH
Stock ticker: NASDAQ
AS OF
Jun 27 closing price
Price
$17.63
Change
-$0.50 (-2.76%)
Capitalization
566.66M

DNTH Dianthus Therapeutics Forecast, Technical & Fundamental Analysis

Dianthus Therapeutics Inc is a clinical-stage biotechnology company dedicated to designing and delivering novel, monoclonal antibodies with improved selectivity and potency over existing complement therapies... Show more

DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I.Advisor
a Summary for DNTH with price predictions
Jun 27, 2025

DNTH's MACD Histogram crosses above signal line

The Moving Average Convergence Divergence (MACD) for DNTH turned positive on June 25, 2025. Looking at past instances where DNTH's MACD turned positive, the stock continued to rise in of 47 cases over the following month. The odds of a continued upward trend are .

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

The Stochastic Oscillator suggests the stock price trend may be in a reversal from a downward trend to an upward trend. of 63 cases where DNTH's Stochastic Oscillator exited the oversold zone resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

Bearish Trend Analysis

The Momentum Indicator moved below the 0 level on June 27, 2025. You may want to consider selling the stock, shorting the stock, or exploring put options on DNTH as a result. In of 99 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .

DNTH moved below its 50-day moving average on June 13, 2025 date and that indicates a change from an upward trend to a downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where DNTH declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

DNTH broke above its upper Bollinger Band on June 12, 2025. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

The Aroon Indicator for DNTH entered a downward trend on June 25, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.725) is normal, around the industry mean (16.366). P/E Ratio (3.238) is within average values for comparable stocks, (58.189). DNTH's Projected Growth (PEG Ratio) (0.000) is slightly lower than the industry average of (2.309). Dividend Yield (0.000) settles around the average of (0.041) among similar stocks. P/S Ratio (97.087) is also within normal values, averaging (252.247).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock slightly better than average.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. DNTH’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

View a ticker or compare two or three
DNTH
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interact to see
Advertisement
A.I. Advisor
published Earnings

DNTH is expected to report earnings to rise 270.73% to -303 cents per share on September 18

Dianthus Therapeutics DNTH Stock Earnings Reports
Q2'23
Est.
$-3.04
Q1'25
Missed
by $0.32
Q4'24
Missed
by $0.01
Q3'23
Missed
by $3.22
Q1'23
Missed
by $0.07
The last earnings report on May 12 showed earnings per share of -81 cents, missing the estimate of -50 cents. With 789.41K shares outstanding, the current market capitalization sits at 566.66M.
A.I. Advisor
published General Information

General Information

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
7 Times Square
Phone
+1 929 999-4055
Employees
53
Web
https://www.dianthustx.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
TRGAX22.200.22
+1.00%
T. Rowe Price Global Industrials I
CSECX33.750.16
+0.48%
Calvert Equity C
FIIAX22.490.10
+0.45%
Fidelity Advisor Mid Cap II A
RYMVX73.05-0.24
-0.33%
Rydex S&P MidCap 400 Pure Value A
KSOCX152.40-1.36
-0.88%
Kinetics Small Cap Opportunities Adv C

DNTH and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, DNTH has been loosely correlated with IMNM. These tickers have moved in lockstep 51% of the time. This A.I.-generated data suggests there is some statistical probability that if DNTH jumps, then IMNM could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To DNTH
1D Price
Change %
DNTH100%
-2.76%
IMNM - DNTH
51%
Loosely correlated
-0.23%
ERAS - DNTH
50%
Loosely correlated
N/A
CRNX - DNTH
48%
Loosely correlated
-0.10%
XNCR - DNTH
48%
Loosely correlated
-3.10%
SYRE - DNTH
47%
Loosely correlated
-4.99%
More